CMPR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CMPR looks fundamentally and technically constructive for a long-term investor, but it is not a strong immediate buy for a beginner with $50,000-$100,000 who is impatient and wants to act now. The stock has already had a strong run, the latest close was slightly below the prior close with a regular-session drop of 4.43%, and the technical setup is positive but not compelling enough to call an urgent entry. Best direct verdict: hold and wait for a cleaner pullback rather than buying aggressively right now.
CMPR's trend is bullish overall: SMA_5 is above SMA_20 and SMA_200, which supports an uptrend. MACD histogram is positive at 0.337, though it is contracting, suggesting momentum is still positive but easing. RSI_6 at 53.712 is neutral, so the stock is neither overbought nor oversold. Price is near the pivot at 98.291 and below resistance at 104.68, with support at 91.901. The short-term chart trend is constructive, but today's regular-market decline and the contracting MACD weaken the urgency of a fresh buy.
Hedge funds are buying, with buying up 155.46% over the last quarter. Recent news shows strong momentum, including a 16.7% gain over four weeks and 30.9% over 12 weeks. Analysts raised targets and stayed constructive: Truist lifted its target to $110 and Barrington raised its target to $113, both with bullish ratings. The company is described as benefiting from sustained demand, good execution, and cross-Cimpress fulfillment. The stock also has a favorable Momentum Score of B and a low P/S ratio of 0.63, which supports a value-plus-growth argument.
There is no AI Stock Picker signal today and no recent SwingMax signal, so no proprietary signal is pushing an immediate entry. RSI is only neutral, and MACD momentum is contracting. The stock fell 4.43% in the regular session, which shows near-term pressure despite the broader trend. Insider trading is neutral, and there is no recent congress trading data or politician activity to add conviction. The latest financial snapshot was unavailable, so the most recent quarterly financial strength cannot be directly confirmed from the provided data.
No detailed financial snapshot was provided because of an error, so latest-quarter revenue, EPS, and margin trends cannot be fully assessed. Still, the available analyst commentary says Q3 results beat expectations for the third time in a row, driven by sustained demand for higher-value offerings, good execution, and cross-Cimpress fulfillment. That implies the latest quarter season was strong and operational trends are improving.
Analyst sentiment is positive and trending upward. On 2026-05-01, Truist raised its price target to $110 from $100 and kept a Buy rating after a better-than-expected Q3. On 2026-05-06, Barrington raised its target to $113 from $95 and kept an Outperform rating, citing positive estimate revisions and a modestly higher valuation assumption. Wall Street's pros view is that earnings momentum, execution quality, and upside to estimates remain supportive. The cons view is that the stock has already appreciated 38% year-to-date, so the easy gains may already be behind it.
